Clinical Trials Using Granisetron Hydrochloride

Clinical trials are research studies that involve people. The clinical trials on this list are studying Granisetron Hydrochloride. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Impact of Anti-nausea Drugs on the Risk of Kidney Injury in Cancer Patients Receiving Cisplatin

    This phase III trial compares whether granisetron, ondansetron, or palonosetron can influence harm to the kidneys, whether cisplatin levels in the body can influence the risk of harm to the kidneys, and whether genetic make-up can increase or decrease the likelihood of kidney injury due to cisplatin therapy. Anti-nausea drugs, such as granisetron, ondansetron, or palonosetron, belong to a class of medications known as 5-hydroxytryptamine antagonists or 5-HT3As and may prevent nausea due to cisplatin treatment. This study may help researchers learn more about the processes that increase the risk of kidney damage from cisplatin therapy.
    Location: 2 locations